BackCara Therapeutics Overview

Cara Therapeutics Total Liabilities

Latest total liabilities for CARA: $9.1M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$9.13M
↓ 15.60% YoYΔ $-1.69M vs prior year quarter

Peer trimmed avg / median

Loading

Cara Therapeutics Total Liabilities History

Loading

Cara Therapeutics vs. peers: Total Liabilities Comparison

Loading

Cara Therapeutics Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Cara Therapeutics (CARA) FAQ

Cara Therapeutics (CARA) currently reports a total liabilities of $9.1M as of June 2026. That compares with $11M in the prior-year period — down 15.6% year over year. Use the charts on this page to explore Cara Therapeutics's total liabilities history and peer comparisons.

Cara Therapeutics's total liabilities decreased from $11M to $9.1M — a 15.6% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Cara Therapeutics reported $9.1M in total liabilities as of June 2026. That compares with $11M in the prior-year period — down 15.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $9.1M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Cara Therapeutics, and consider following CARA for alerts when major investors trade the stock.

Cara Therapeutics is classified in the Healthcare sector. On total liabilities, it currently shows $9.1M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CARA with unrelated industries.